These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10372266)

  • 1. GAD antibodies in classification of Asian type 2 diabetes.
    Fukui M; Nakamura N; Kondo M
    Diabetes Care; 1999 Jun; 22(6):1011-2. PubMed ID: 10372266
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical heterogeneity of patients with adult-onset diabetes and GAD autoantibodies.
    Fukui M; Kitagawa Y; Nakamura N; Yoshikawa T
    Diabetes Care; 2002 Dec; 25(12):2363-4; author reply 2364-5. PubMed ID: 12453997
    [No Abstract]   [Full Text] [Related]  

  • 3. GAD antibodies in IDDM in Thailand.
    Rattarasarn C; Aguilar-Diosdado M; Soonthornpun S; Patarakijvanich N; Jaruratanasirikul S
    Diabetes Care; 1996 Jun; 19(6):674-5. PubMed ID: 8725876
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to GAD in elderly patients with previously diagnosed NIDDM.
    Fukui M; Nakamura N; Nakano K; Sawada M; Aoji O; Obayashi H; Shigeta H; Kondo M
    Diabetes Care; 1998 Apr; 21(4):675-6. PubMed ID: 9571369
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B; Zimmy S; Schatz H; Pfohl M
    Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A 81-year-old case of latent autoimmune diabetes mellitus in adult].
    Wang TQ; Liu YS; Qu GY; Xiao X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):369. PubMed ID: 16136990
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 8. Islet cell autoimmunity in youth onset diabetes mellitus in Northern India.
    Goswami R; Kochupillai N; Gupta N; Kukreja A; Lan M; Maclaren NK
    Diabetes Res Clin Pract; 2001 Jul; 53(1):47-54. PubMed ID: 11378213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroconversion of glutamic acid decarboxylase antibodies in a patient initially diagnosed as having type 2 diabetes mellitus.
    Nagai T; Imamura M; Mori M
    Intern Med; 2005 Apr; 44(4):299-302. PubMed ID: 15897639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes.
    Banerji MA; Chaiken RL; Huey H; Tuomi T; Norin AJ; Mackay IR; Rowley MJ; Zimmet PZ; Lebovitz HE
    Diabetes; 1994 Jun; 43(6):741-5. PubMed ID: 8194658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [When and why should anti-GAD antibodies by looked for in the non-insulin-dependent diabetic patient?].
    Atlan-Gepner C; Vialettes B
    Diabetes Metab; 1999 Jun; 25(2):177-9. PubMed ID: 10443330
    [No Abstract]   [Full Text] [Related]  

  • 12. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
    Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
    Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up.
    Pitteloud N; Philippe J
    Schweiz Med Wochenschr; 2000 Apr; 130(16):576-82. PubMed ID: 10842773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years.
    Ramachandran A; Snehalatha C; Satyavani K; Sivasankari S; Vijay V
    Diabetes Care; 1999 Jan; 22(1):175-6. PubMed ID: 10333923
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa.
    Panz VR; Kalk WJ; Zouvanis M; Joffe BI
    Diabet Med; 2000 Jul; 17(7):524-7. PubMed ID: 10972582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes.
    Beischer NA; Wein P; Sheedy MT; Mackay IR; Rowley MJ; Zimmet P
    Am J Obstet Gynecol; 1995 Nov; 173(5):1563-9. PubMed ID: 7503202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of type I and II diabetes in newly diagnosed diabetic patients: Measuring C-Peptide level.
    Shahbazian H; Aleali AM; Rashidi H; Latifi SM; Rashidi M; Yazdanpanah L; Zaman F; Payami SP; Moradi L; Jahanshahi A; Sedaghat A; Zakerkish M; Moradi M
    Diabetes Metab Syndr; 2019; 13(3):1833-1835. PubMed ID: 31235102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroconversion of GAD antibody in unclassified diabetes with long duration of disease.
    Shigihara T; Shimada A; Saisho Y; Kawai T; Maruyama H; Saruta T
    Diabetes Care; 2004 Jul; 27(7):1836-7. PubMed ID: 15220276
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes.
    Li X; Zhou ZG; Huang G; Yan X; Yang L; Chen XY; Wang JP
    Ann N Y Acad Sci; 2004 Dec; 1037():122-6. PubMed ID: 15699504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.